Idiotypes are antigenic determinants on variable (V) 1 regions of antibodies. Two types of idiotypes have been described. Individual specificities or idiotypes (IdI) unique to a specific antibody (1) (2) (3) (4) (5) ; cross-specific idiotypes (IdX) shared among immunoglobulins that are usually functionally related (4) (5) (6) (7) (8) (9) (10) .
IdI and IdX determinants have been found on human (1-4, 8, 11) , rabbit (12) (13) (14) (15) (16) (17) , and mouse antibodies (5-7, 9-10, 18-28) . Antigenic specificities that determine IdI and IdX have been localized to V region light chain (VL), V region heavy chain (VH), or to both chains (2, 8, (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) ). An idiotype can be localized to or near a complementary region when anti-idiotype antibody is blocked by hapten.
Many IdX have been shown to be genetically controlled (20) (21) (22) (23) (24) (25) (26) (27) (28) . In the mouse genes controlling al-3 dextran (24) , phosphorylcholine (23) , phenylazoarsonate (22) , and inulin (28) , cross-specific idiotypes were shown to be linked to the allotype (CH).
In BALB/c mice a series of 11 myeloma proteins that bind inulin, and bacterial levan have been described (10, 28) . These proteins all have hapten-binding specificity for a series of fl2,1-1inked fructan oligosaccharides. Each of the proteins in this group has individual antigenic (idiotypic) specificities (IdI) as well as one or more shared idiotypes (IdX). IdI and IdX antisera can be prepared in the homologous species, and hence are used in detecting polymorphic differences between strains.
Genetic analysis has shown that the cross-reacting hapten inhibitable idiotypes on the inulin-binding myeloma proteins (InuBMP) are linked to allotype (28) , which suggests that these idiotypes may be useful as markers for genes coding for the VH region. However, their use as such is limited until the light chains are shown not to contribute to the expression of the idiotypes. If the idiotype reflects conformational contribution of both VL and VH, then it reflects structures controlled by two different unlinked genes and such genetic studies are precluded unless one uses strains which have similar VL repertoires for inulin. In the present study, recombinants of different InuBMP were prepared to determine if the idiotypes associated with InuBMP could be localized.
Materials and Methods
Myeloma Proteins. The BALB/c IgA InuBMP used in this study have been previously described and include EPC109 (El09), Aml (A1), ABPC4 (A4), TEPCS03 (T803), W3082, UPC61
1 Abbreviations used in this paper: HA, hemagglutination; HI, hemagglutination inhibition; IdI, individual idiotypes; IdX, cross-specific idiotype; InuBMP, inulin-binding myeloma proteins; V, variable; Vm variable region heavy chain; VL, variable region light chain.
(U61), ABPC47N (A47N), and a new protein TEPC957 (T957) (10) . All of these proteins agglutinate beth inulin (~2,1 fructan) and bacterial levan (fl2,1-2,6 fructan) coated SRBC. The InuBMP were purified on affinity columns with inulin-coupled Sepharose 4B (39) . Another protein, XRPC24 (X24), used in these studies which binds galactan and not inulin was purified on a bovine serum albumin galactoside column (40) .
Anti-ldiotype Antisera. Production of anti-idiotype antisera has been described (10) . A/He mice were immunized with each of the InuBMP and the antisera were made specific for inulin idiotypes by absorption with a BALB/c IgA non-InuBMP. Anti-IdI antisera were made specific by absorbing anti-idiotype antisera with the cross-reactive InuBMP (10) .
Assay to Determine Specificity of Anti-ldiotype Antibody. Antisera were tested in the hemagglutination (HA) and hemagglutination inhibition (HI) systems for idiotypic antibodies as previously described (10) . SRBC coated with a specific InuBMP by the chromic chloride method (10) were tested with anti-idiotype antiserum and the HA titer was determined for each of the InuBMP. The antiserum was tested with each of the InuBMP SRBC with which it cross-reacted; the InuBMP were then used as inhibitors of this system and the HI titer was determined.
Titration of Inulin and Levan Antibodies. Inulin and levan antibody titers were determined by HA with SRBC coated with O-stearoyl inulin or levan (28) . Levan was obtained from culture supernates ofAerobacter laevanicum ATCC 15552 (28) .
Separation and Reeonstitution of H and L Chains of Myeloma Proteins.
The method for separating L and H chains has been described (41) , and consisted of dialyzing the purified protein against 0.15 M Tris-HC1-0.15 M NaC1-2 mM Na2 EDTA, reduction with 10 mM dithiothreitol, and alkalation with 20 mM iodoacetamide. The chains were separated on a G100-6M urea Sephadex column. Purity of H and L chain preparations was checked by polyacrylamide gel electrophoresis in 0.1% sodium dodecyl sulfate and contamination was found to be <2%. The H and L chain was recombined as described by Manjula et al. (42) . Recombinants from three protein pairs were made: E109-U61, A4-T957, and E109-X24 and put on a Sephadex G200 column to isolate the recombinant monomers (H2L2 tool wt 180,000). Monomers ofrecombinants of E109H + U61L, E109L + U61H, A4H + T957L, A4L + T957H, E109H + X24L, and E109L + X24H were obtained with a yield of 25-90% of the total protein applied to the column. Dr. D. J. Streetkirk of the National Cancer Institute, National Institutes of Health kindly determined by fluorescence titration, that the binding sites of all the monomers were functional except for E109-X24 which did not bind inulin or galactan.
Results

Inulin and Levan Activity of Recombinants of L and H Chains of U61, E109, A4, and T957 InuBMP. Monomers of recombinant molecules of U61L
+ E109H and U61H + E109L were tested for HA of SRBC coated with inulin and bacterial levan (Table I) . Both recombinants agglutinated inulin-and levan-coated SRBC with titers similar to the U61 and El09 7S molecules. No agglutination was obtained with U61 or El09 L and H chains alone.
Similarly, monomers of recombinants of A4L + T957H and A4H + T957L agglutinated inulin-and levan-coated RBC while, A4H or A4L alone showed no agglutination. When recombinants were made between El09 and X24, the recombinant molecules did not agglutinate inulin-and levan-coated SRBC.
Localization of Individual Idiotypes of U61, E109, A4, and T957 to Specific
InuBMP Immunoglobulin Chains. Antisera specific for only the InuBMP used in its preparation identify individual antigenic specificities (IdI) ( Table  II) . Monomers of recombinant molecules of L and H chains from four different InuBMP (U61, El09, A4, and T957) were used as inhibitors of anti-IdI sera each reacting with SRBC coated with the homologous protein. Recombinant molecules made with homologous chains (e.g., E109L-E109H) retained their IdI (Figs. 1-4). Dissociated L and H chains did not inhibit IdI antisera. IdI antisera for El09, U61, T957, and A4 identified antigenic determinants which were expressed only when the L chains of these four respective proteins were present (Figs. 1-4) since the anti-IdI sera for each of these proteins could only be inhibited by molecules containing the appropriate L chain. In the case of A4 IdI some A4H was also required for its expression (Fig. 4) . The IdI of U61, El09, and T957 are not inhibitable by the hapten fructan trisaccharide while the A4 IdI is associated with the antibody site and is hapten inhibitable.
Localization of Cross-Specific Idiotypes (IdXB System). In addition to IdI,
InuBMP share idiotypes (IdX) with other InuBMP. IdX determinants can also be shared by normal inulin antibodies (28) . One IdX, IdXB, specificity has been previously described (10, 28) and was found on U61, W3082, and T803 but not on El09, A4, A47N, Aml, and T957 InuBMP. Antisera used to identify InuIdXB are shown in Table III . Recombinant molecules U61L + E109H and U61H + E109L were used to inhibit the anti-InuIdXB system. Specifically anti- T803 (serum 10914) absorbed with El09 tested with W3082-coated SRBC was inhibited by U61 but not El09, and was also inhibited by U61L + E109H but not by U61H + E109L or by E109L and H chains alone (Fig. 5) A47N (I0, 28) . Antisera identifying the InuIdXA system are shown on Table IV . In addition antisera identifying another specificity (not previously described) designated InuldXA' showed the same pattern of crossreactions as InuldXA except that it also cross-reacted with A47N (Table IV) . Recombinant molecules A4H + T957L and A4L + T957H were used as inhibitors of the anti-IdXA and anti-ldXA'. Anti-El09 serum absorbed with T957 and tested with A4-coated SRBC was inhibited by A4 but not T957, and was also inhibited by A4H + T957L but not by A4L + T957H nor A4L or A4H chains alone (Fig. 6) . The IdXA determinant was associated with the A4H chain but required an InuBMP L chain. InuIdXA is an inulin cross-specific idiotype found on A4, W3082, T803, U61, and El09. A new InuIdXA-like cress idiotype (A') is similar to InuIdX except that it is also present on A47N. conformation such that the L chain idiotype can be expressed. Whatever the role of the H chain is in idiotypic expression, it is likely that the VH from an InuBMP is necessary since the H chain from a galactan-binding myeloma protein (X24) combined with E109L chain didn't result in expression of any El09 idiotypes.
FIG. 3. Localization of T957 IdI to T957 L chain; also requires an H chain of an InuBMP to be expressed. Recombinant molecules of L and H chains of T957 and A4 InuBMP were tested as inhibitors of specific anti-T957 serum reacted with T957-coated SRBC. T957 IdI is not in the antibody-combining site and is not inhibitable (NI) by fructan trisaccharide. W3082 is an InuBMP.
Ig CHAIN LOCATION OF A4
There have been many idiotypes linked to allotype reported in the mouse, including the IdXB idiotype associated with U61L discussed in this paper (22) (23) (24) 28) . It is often assumed that these idiotypes are markers for genes coding for the VH region since there is linkage of VH to CH (22) (23) (24) (25) (26) (27) (28) 43) . The contribution of the L chain to expression of these idiotypes must be understood before these markers can be used in genetic studies. For example in previous genetic studies (28) it was presumed that InuIdXB was a VH marker since it appeared to be associated with the BALB/c CH allotype. In these studies backcross progeny of BALB/c (IdXB +) × C57BL (IdXB-)F1 x C57BL showed that the 50% of the progeny which carried the BALB/c allotype were IdXB + while the 50% lacking the BALB/c allotype were IdXB-. However, linkage of IdXB to allotype is difficult to understand since the findings in this paper show that the InuIdXB idiotype is determined by L chain differences questions the former assumption that InuIdXB is a VH marker, but shows instead that it is a marker for a specific VH-VL pair which depends on the structure of VL for its expression. Thus the backcross data may indicate: (a) that there is no polymorphism of the L chain and the VL of BALB/c and C57BL are the same but require the appropriate Vs (BALB/c) to be expressed? or (b) that there is indeed polymorphism of the L chains but selection among the L chains of C57BL for the appropriate L chain to pair with the VH of BALB/c is regulated by the H chain of BALB/c? Congenic strain data (28) permits further analysis of idiotype genetics. CB20 presumably has the L chains of BALB/c and the H chain of C57BL and is IdXB-, indicating that it has the wrong VH for the VH-V~. pair that determines IdXB. BAB14 on the other hand is identical to CB20 except that at the 14th generation when a separate line was established a crossover occurred in the VH region so that VL and VH markers are of the BALB/c type and the CH is of the C57BL type. This strain is IdXB +, showing expression of the appropriate VL-VH pairs.
The more provocative finding is in the BC-8 congenic strain which presumably has the C57BL L chain and BALB/c H chain. These mice are IdXB +, which suggests: (a) that the L chain of C57BL and BALB/c are the same and either one uses the Vu of BALB/c to express IdXB or (b) that there is regulation of the C57BL L chain by the H chain of BALB/c which selects among the L chains, for the appropriate one, permitting expression of IdXB.
IdXB can be used as both a H and L chain marker as long as proper strain combinations are used. The idiotype is potentially useful as a L chain marker so long as both parental strains have the same or permissive VH genes. Specifically, the VH in BALB/c and RIII appear to be very similar because IdXA and IdXG are present in both while the IdXB is lacking in RIII (28) .
Conversely, to study the genetic differences of a VH, it must first be shown that the strains compared have similar VL. Idiotypes linked to allotypes should not be considered VH markers until it is demonstrated that the L chains in the strains involved are not polymorphic.
Summary
Idiotypes of inulin-binding myeloma proteins (InuBMP) were determined primarily by variable region light chains (VL) or by variable region heavy chains (VH) but needed both chains to be expressed. Recombinant molecules were used to show that individual idiotypes (IdI) of U61, EI09, T957, and A4 InuBMP and cross-specific idiotypes (IdXB) of U61 were primarily determined by V L while cross-specific idiotype (IdXA) of A4 was determined mainly by VH. The assignment of genes controlling idiotypes to VH based on allotype linkage (e.g., IdXB) is dubious until the role of the L chain in determining that idiotype is assessed. IdXB has been shown to be a VL-V H marker which presumably is controlled by two unlinked genes. However IdXB can be used as a L chain marker in combinations of strains differing in their L chain genes but having the same permissive H chain genes. Conversely IdXB can be used as a H chain marker in strains having the same permissive L chain genes but differing in their H chain genes.
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